MD, PhD, MBA
Dr. David Greene, MD, PhD, MBA, stands at the forefront of regenerative medicine and healthcare innovation, blending clinical expertise with entrepreneurial vision. As the founder and CEO of R3 Stem Cell and US Lead Network, Dr. Greene has dedicated his career to advancing patient care and empowering medical practices through advanced therapies and digital marketing excellence.
A residency and fellowship-trained orthopedic surgeon, Dr. Greene began his journey in medicine with a deep commitment to helping others. After years in clinical practice, he recognized the transformative potential of regenerative therapies and the urgent need for better patient access and education. This insight led him to establish R3 Stem Cell, now a global leader in non-surgical treatment options using stem cell and PRP therapy. Under his leadership, R3 Stem Cell has performed over 26,000 procedures across more than 45 international clinics, offering hope and healing to patients worldwide.
Dr. Greene’s entrepreneurial spirit didn’t stop at clinical innovation. He also founded US Lead Network, a healthcare internet marketing company that leverages artificial intelligence to help medical and dental practices grow their patient base efficiently and ethically. His two books on healthcare internet marketing have become essential reading for providers seeking to navigate the complexities of digital patient acquisition. Recognized as a Top 20 Expert Author by Ezines.com – ranking #15 out of over 470,000 authors and #1 in Pain Management – Dr. Greene’s thought leadership has shaped the way healthcare professionals connect with patients online.
A defining moment in Dr. Greene’s career was his decision to leave clinical practice and focus entirely on innovation and education. “I’ve never been a fan of just settling for the status quo. Innovation is a cornerstone of what makes America great,” he reflects. This philosophy has driven R3 Stem Cell’s mission to provide affordable, high-quality regenerative care and to demystify stem cell therapies through comprehensive training courses and educational content for both providers and patients.
Dr. Greene’s work has garnered international recognition, including a feature on the cover of Corporate Vision magazine, where his commitment to affordable, accessible regenerative therapies was spotlighted. His impact extends beyond business metrics – he is known for his compassionate approach, always prioritizing patient education and ethical practice.
Outside of his professional life, Dr. Greene is inspired by the words of Maya Angelou: “My mission in life is not merely to survive, but to thrive; and to do so with some passion, some compassion, some humor, and some style”. He brings this ethos to his daily work, fostering a culture of innovation, empathy, and continuous learning.
When he’s not leading global healthcare initiatives, Dr. Greene enjoys sharing insights on social media, connecting with colleagues, and pursuing personal interests that keep him grounded and inspired.
Dr. David Greene’s journey is a testament to the power of combining clinical skill, business acumen, and a heartfelt commitment to making a difference – one patient, one practice, and one innovation at a time.
All Posts
In the rapidly evolving landscape of regenerative medicine, one term has risen to the top of clinical research and patient interest: Wharton’s Jelly. Often hailed as the most potent source of mesenchymal stem cells (MSCs), this substance is a cornerstone of modern biologics. But what
Cerebral Palsy (CP) is a complex neurological condition, often resulting from early brain trauma or developmental issues such as Periventricular Leukomalacia (PVL). For many families, traditional therapies, while essential, can sometimes reach a plateau where progress feels stagnant. In recent years, regenerative medicine has emerged
Trigeminal Neuralgia (TN) is often described as one of the most painful conditions a human being can experience. Characterized by sudden, electric-shock-like facial pain, it can make basic activities like eating, speaking, or even washing one’s face an agonizing ordeal. For many patients, the standard
Advancing Lung Health: Stem Cell Therapy for COPD and Pulmonary Fibrosis in Dubai For patients living with Chronic Obstructive Pulmonary Disease (COPD) or Pulmonary Fibrosis, the world often feels like it is shrinking. Many patients come to us after being told by their pulmonologists that
Key Takeaways Muse cells are a naturally occurring subpopulation of mesenchymal stem cells (MSCs) that exhibit pluripotent-like properties, meaning they can differentiate into cell types from all three embryonic germ layers. Discovered in 2010 at Tohoku University in Japan by Dr. Mari Dezawa and her
If you’ve been researching regenerative medicine, you may have come across a newer term making waves in the stem cell world — MUSE stem cells. At R3 Stem Cell, we’ve been receiving a growing number of questions about MUSE cells, how they differ from traditional
R3 Stem Cell has been granted both a Restraining Order and an Injunction versus Kathleen Francesca, whose real name is Kathleen Tangcoy Legaspi. She’s been representing herself even now as an officer of R3 Stem Cell. She sells product, takes the customer’s monies into her
Dr. David Greene, the Founder, and CEO of R3 Stem Cell has been featured on the cover of Corporate Vision magazine for July 2021. Dr. Greene’s company is the leader in global regenerative therapies, with over stem cell procedures performed worldwide in the past decade.
